Peptide YY Finding in recent paper
Next-generation agents are now being developed that engage not only GLP-1 receptors but also those for peptide YY to enhance energy uptake, storage, and expenditure through synergistic mechanisms.
Peptide YY is a gut hormone released after eating that signals fullness through a completely different pathway than GLP-1. It acts on the brain directly via the vagus nerve and affects energy expenditure as well as appetite. Adding it to a GLP-1 framework theoretically addresses satiety from two independent hormonal directions simultaneously.
The drugs incorporating this are still in early development. But the direction of travel in this field is now clearly toward combinations of gut hormones rather than optimizing any single one. The question of how many receptors you can activate simultaneously before you hit diminishing returns or novel side effect profiles is one nobody has answered yet.